Assistance Listing 93.326
Strengthening Public Health Through Surveillance, Epidemiologic Research, Disease Detection and Prevention
Centers for Disease Control and Prevention · Department of Health and Human Services
The verdict for a small nonprofit
Rarely funds nonprofits directly. 100% of awards go to governments and other applicants, so look for a subrecipient or partner role instead.
Based on 1 new awards in FY2021–23. The median award is $3,776,452. Expect about 85 days between posting and deadline.
- First-time winners
- —
- of new awards, last 3 FYs
- Nonprofit share
- 0%
- 0% higher ed · 0% gov't
- Under-$1M orgs
- n/a
- revenue join unavailable
- Median award
- $3.8M
- $3.8M – $3.8M middle half
- New awards, FY2023
- 1
- $3.8M committed to them
- Usually posts
- Dec
- annual · 85-day window
Open right now under this program
1 opportunity · from Grants.gov, checked every 10 minutes
| Deadline | Opportunity | Expected awards |
|---|---|---|
| Apr 5155 days | NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)PA-27-100 | — |
Who won in FY2023
Largest recipients by dollars. From USAspending.
| Recipient | Type | State | Awards | Awarded |
|---|---|---|---|---|
| Cherokee Nation | Tribal | OK | 1 | $3,776,452 |
| JAN Biotech, INC. | Business | NY | 1 | $275,766 |
| Vectech, INC. | Business | MD | 1 | $275,766 |
| Fluxus, INC. | Business | CA | 1 | $230,283 |
| Giner, INC. | Business | MA | 1 | $212,083 |
New awards by fiscal year
Awards first made in each fiscal year; dollars are the total committed to that year's new awards over their life.
| FY | New awards | Committed | Median | Middle half |
|---|---|---|---|---|
| 2021 | 2 | $442K | $221K | $217K – $226K |
| 2022 | 2 | $552K | $276K | $276K – $276K |
| 2023 | 1 | $3.8M | $3.8M | $3.8M – $3.8M |
Past rounds
Every announcement under this listing that Grants.gov still lists. Use it to plan next year.
| Posted | Closed | Window | Announcement |
|---|---|---|---|
| 2026-06-04 | 2026-07-06 | 32 d | RFA-CK-26-104 · Eliminating Parasitic and Neglected Tropical Disease Threats to the United States - Program Support and Research to Reduce Threats to Americans at Home and Abroad |
| 2026-05-28 | 2027-04-05 | 312 d | PA-27-100 · NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) |
| 2026-05-11 | 2026-06-22 | 42 d | RFA-JG-26-034 · Enhancing Understanding of and Preparedness for Public Health Threats Through Research in Kenya |
| 2024-11-25 | 2025-02-12 | 79 d | RFA-CK-25-035 · Monitoring, Operations Research, Evaluation of Tools for Malaria Control and Prevention in Kenya |
| 2023-12-22 | 2024-03-07 | 76 d | RFA-IP-24-017 · Collaborative research on influenza and other respiratory pathogens in South Africa |
| 2023-12-14 | 2024-03-08 | 85 d | RFA-GH-24-033 · Advancing Public Health Research in Bangladesh |
| 2022-12-02 | 2023-03-13 | 101 d | RFA-GH-23-003 · Conducting Public Health Research with Universities in Thailand |
| 2022-11-28 | 2023-03-10 | 102 d | RFA-GH-23-001 · Enhancing Capacity for Strategic and Applied Research Activities in Support of Control and Elimination of Neglected Tropical Diseases |
| 2022-06-02 | 2023-04-05 | 307 d | PA-22-176 · PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) |
| 2022-06-02 | 2023-04-05 | 307 d | PA-22-177 · PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) |
| 2021-12-20 | 2022-03-01 | 71 d | RFA-GH-22-001 · Enhancing Capacity for Strategic and Applied Research Activities in Support of Control and Elimination of Malaria and Other Parasitic Diseases |
| 2021-07-08 | 2022-04-05 | 271 d | PA-21-259 · PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) |
| 2021-07-08 | 2022-04-05 | 271 d | PA-21-260 · PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) |
| 2020-12-30 | 2021-03-09 | 69 d | RFA-IP-21-003 · Collaborative Research on Influenza, Coronavirus Disease 2019 (COVID-19), and Other Respiratory Pathogens in South Africa |
| 2020-11-16 | 2021-02-22 | 98 d | RFA-GH-21-006 · Strengthening Public Health Research and Implementation Science (Operations Research) to Control and Eliminate Infectious Diseases Globally |
| 2020-11-10 | 2021-03-15 | 125 d | RFA-GH-21-001 · Conducting Public Health Research in Thailand: Technical collaboration with the Ministry of Public Health (MOPH) in the Kingdom of Thailand |
| 2020-11-03 | 2021-02-15 | 104 d | RFA-GH-21-003 · Advancing Public Health Research in Kenya |
| 2020-07-13 | 2021-04-05 | 266 d | PA-20-262 · PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) |
| 2020-07-13 | 2021-04-05 | 266 d | PA-20-260 · PHS 2020-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) |
| 2020-07-13 | 2021-04-05 | 266 d | PA-20-261 · PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) |
| 2020-02-26 | 2020-03-31 | 34 d | RFA-GH-20-003 · Conducting Public Health Research in Colombia |
| 2020-01-09 | 2020-03-09 | 60 d | RFA-GH-20-005 · Conducting Public Health Research in South America |
| 2020-01-09 | 2020-03-09 | 60 d | RFA-GH-20-004 · Conducting Public Health Research in Georgia |
| 2019-12-26 | 2020-03-16 | 81 d | RFA-GH-20-002 · Malaria Operations Research to Improve Malaria Control and Reduce Morbidity and Mortality in Western Kenya |
| 2019-05-07 | 2020-07-06 | 426 d | PA-19-273 · PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required |
| 2019-05-07 | 2020-07-06 | 426 d | PA-19-272 · PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed |
| 2019-03-03 | 2019-03-12 | 9 d | RFA-GH-19-013 · Advancing Infectious Disease Detection and Response in Liberia |
| 2019-01-04 | 2019-03-04 | 59 d | RFA-GH-19-003 · Advancing Infectious Disease Detection and Response in Senegal |
| 2019-01-04 | 2019-03-29 | 84 d | RFA-GH-19-010 · Advancing Infectious Disease Detection and Response in Nigeria |
| 2018-12-21 | 2019-02-27 | 68 d | RFA-GH-19-006 · Advancing Infectious Disease Detection and Response in Indonesia |
| 2018-12-21 | 2019-03-07 | 76 d | RFA-GH-19-005 · Advancing Public Health Research in Bangladesh |
| 2018-12-21 | 2019-03-11 | 80 d | RFA-GH-19-009 · Advancing Infectious Disease Detection and Response in Viet Nam |
| 2018-12-21 | 2019-02-27 | 68 d | RFA-GH-19-008 · Advancing Infectious Disease Detection and Response in Uganda |
| 2018-12-19 | 2019-03-22 | 93 d | RFA-GH-19-015 · Malaria Operations Research to Improve Malaria Control and Reduce Morbidity and Mortality in Malawi |
| 2018-01-19 | 2018-03-20 | 60 d | RFA-GH-18-002 · Strengthening detection of emerging infectious diseases in India |
| 2018-01-16 | 2019-04-05 | 444 d | PA-18-574 · PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) |
| 2018-01-11 | 2018-03-12 | 60 d | RFA-GH-18-005 · Enhancing Capacity for Strategic and Applied Research Activities in Support of Control and Elimination of Malaria and Neglected Tropical Diseases |
| 2018-01-09 | 2018-03-09 | 59 d | RFA-GH-18-004 · Advancing Public Health Research in Central America (Belize, Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras, Nicaragua, Panama): Amendment 1 |
| 2017-06-05 | 2018-01-05 | 214 d | PA-17-302 · PHS 2017-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) |
| 2017-03-09 | 2017-05-09 | 61 d | RFA-GH-17-005 · Conducting Public Health Research in China |
Common questions
How hard is it to win a grant under 93.326?
Rarely funds nonprofits directly. 100% of awards go to governments and other applicants, so look for a subrecipient or partner role instead. Based on 1 new awards in FY2021–23. The median award is $3,776,452. Expect about 85 days between posting and deadline.
How much does Strengthening Public Health Through Surveillance, Epidemiologic Research, Disease Detection and Prevention award?
In FY2023 the median new award was $3.8M; the middle half ran from $3.8M to $3.8M. 1 new awards were made, with $3.8M committed to them.
When does 93.326 usually post?
Over the last several years, new rounds most often posted in Dec with about 85 days to apply. The most recent round posted Jun 4, 2026.
Who runs this program?
Department of Health and Human Services (Centers for Disease Control and Prevention). Assistance Listing 93.326 on SAM.gov describes the authorizing statute and standard terms.
Sources: USAspending FY2021–25 award archive (2026-10-06); Grants.gov Search2 (fetched 2026-10-28); IRS EO BMF (fetched 2026-10-28). Award counts are new awards by fiscal year of first action. Shares are computed from award counts, not dollars. Recipient type comes from the award record's business-type codes. Always confirm details in the official announcement.